The FDA’s New Approach to “No Artificial Colors” Claims: Compliance Risks and Legal Considerations

The U.S. Food and Drug Administration has announced a new enforcement approach to products labeled “no artificial colors,” signaling heightened scrutiny for food and beverage companies that rely on clean-label marketing. While the phrase may appear straightforward, the regulatory analysis behind it is far more nuanced.

As outlined in the FDA’s official press announcement, the agency is clarifying how it evaluates these statements and when they may mislead consumers. Companies that fail to align their formulations, labeling, and advertising with this updated posture may face regulatory consequences. Understanding the latest fda guidance on no artificial colors is essential for brands operating in today’s compliance-driven marketplace.

What the FDA’s New Policy Means for “No Artificial Colors” Claims

The FDA’s recent communication does not create a brand-new regulation. Rather, it signals how the agency intends to interpret and enforce existing laws when companies use “no artificial colors” or similar representations on product labels and in marketing.

Overview of the FDA’s Updated Position on Artificial Color Labeling

Under the Federal Food, Drug, and Cosmetic Act, color additives are strictly regulated. Some require certification, while others are exempt. The FDA’s announcement makes clear that simply avoiding certified synthetic dyes does not automatically justify a “no artificial colors” claim if other ingredients function as color additives in a way consumers may not expect.

The agency emphasized that claims must be truthful and not misleading in context. A label may technically comply with ingredient listing requirements yet still present risk if the marketing message creates an inaccurate consumer impression. This reflects the FDA’s broader approach to food labeling enforcement and its focus on real-world consumer understanding.

How the FDA Evaluates “No Artificial Colors” and Similar Marketing Statements

The FDA does not evaluate labeling in isolation. Instead, it considers the totality of the label, including front-of-package claims, imagery, and ingredient disclosures. When assessing statements such as “no artificial colors,” regulators examine whether any ingredient could reasonably be viewed as providing color in a way that contradicts the claim.

For example, if a product contains ingredients added primarily for coloring—even if derived from natural sources—the FDA may evaluate whether the marketing statement implies a broader absence of color additives than is accurate. This approach mirrors how the agency reviews other FDA food marketing claims, particularly those related to “natural” or “free-from” statements.

Differences Between Regulatory Definitions and Consumer-Facing Claims

A key compliance challenge lies in the gap between technical definitions and consumer perception. From a regulatory standpoint, an ingredient may be classified under FDA rules. However, the agency’s concern is whether the average consumer could be misled by the overall presentation.

This distinction becomes critical in the context of natural claims compliance. A product may meet the literal regulatory definition of a color additive exemption but still create risk if the claim overstates what has been removed or avoided. Companies must therefore evaluate both the legal classification of ingredients and the role of marketing language in shaping consumer expectations.

Compliance Risks for Food and Beverage Companies

The FDA’s announcement is a clear signal that scrutiny of color-related claims is increasing. For food and beverage brands competing in a “clean label” marketplace, the temptation to use bold front-of-package statements can be significant. But without careful analysis, those claims may trigger enforcement.

When “No Artificial Colors” Claims May Be Considered Misleading

A claim may raise red flags if:

• An ingredient functions as a color additive, even if not synthetically produced.
• Marketing materials imply a broader health or safety advantage unsupported by regulation.
• The claim conflicts with the ingredient list or manufacturing realities.

In these situations, regulators may view the statement as misleading labeling artificial color representations, particularly if consumers could interpret the claim as meaning “no added colors at all.”

Label Review, Ingredient Disclosures, and Enforcement Exposure

Every word on a food label is subject to scrutiny. Transparency in the ingredient deck is paramount. If your front-of-package claim says “No Artificial Colors,” but the ingredient list includes a synthetic lake or dye, the contradiction constitutes a “misbranded” product. Regular ingredient and label reviews are essential to ensure that every formulation component aligns with the marketing narrative.

Brands that rely heavily on “free-from” positioning should also ensure documentation supports their representations. In the absence of such documentation, companies may struggle to defend their claims if questioned by regulators.

Potential Consequences: Warning Letters, Product Relabeling, and Market Withdrawal

When the FDA identifies problematic claims, consequences may escalate quickly. These can include:

• Formal warning letters outlining alleged violations.
• Requests for corrective labeling changes.
• Voluntary or mandatory market withdrawal of affected products.
• Increased scrutiny of future submissions and inspections.

Beyond regulatory action, reputational harm and retailer pressure can compound the impact. Clean-label positioning is often central to brand identity, making enforcement action particularly disruptive.

How Companies Can Mitigate Risk and Strengthen Labeling Compliance

While the FDA’s position raises the bar for substantiating “no artificial colors” claims, proactive compliance strategies can significantly reduce exposure.

Conducting Regulatory Reviews Before Launching Marketing Claims

Before any new packaging hits the shelves, companies should perform a comprehensive audit of their food marketing claims. This involves verifying the source of every pigment against the official FDA Color Additive Status List to ensure the substance is authorized for the specific food category intended.

Internal marketing teams may view “no artificial colors” as straightforward, but legal review ensures alignment with the FDA’s current enforcement priorities. Early review is far less costly than post-launch corrective action.

Strategic Pathways for New Ingredients: The Color Additive Petition

For many companies, the shift to “no artificial colors” is limited by the current list of FDA-approved natural colorants. If a company identifies a botanical or mineral-based color that is not currently listed in 21 CFR Part 73, they are not necessarily at a dead end.

At FDA Atty, we assist innovative food and beverage companies in filing Color Additive Petitions to get new, naturally derived ingredients officially approved for use. This process involves:

• Compiling robust safety and toxicological data.
• Defining specific identity and purity standards for the new colorant.
• Navigating the FDA’s formal notice-and-comment rulemaking process.

Engaging a food and beverage regulatory attorney to manage a petition not only opens the door for a “no artificial colors” claim for your specific product but can also establish your company as a first-mover in the “clean label” category. Contact us for support with petition filing and approval.

Aligning Formulation, Labeling, and Advertising with FDA Expectations

Compliance does not end with a single label check. Companies must ensure formulation decisions support marketing language. If an ingredient’s primary purpose is coloring, the associated claim must be evaluated carefully.

Consistency across packaging, online content, and promotional materials is equally important. Regulators assess the total marketing message, not isolated statements. A coordinated compliance strategy helps prevent contradictions that could trigger scrutiny.

How FDA Atty Supports Companies Facing Labeling Scrutiny or Enforcement Action

Navigating the complexities of federal food law requires specialized expertise. At FDA Atty, we provide comprehensive legal support for manufacturers, from pre-market ingredient analysis to defending against enforcement actions. We assist companies in:

• Reviewing and revising labeling claims before product launch.
• Responding to FDA inquiries and warning letters.
• Developing corrective action plans to mitigate risk.
• Advising on broader compliance strategies related to ingredient disclosure and marketing.

The FDA’s updated stance on “no artificial colors” claims underscores a broader regulatory trend: marketing language must reflect not only technical accuracy but also consumer perception. Companies that treat compliance as a strategic priority rather than a last-minute checklist will be better positioned to avoid enforcement actions and maintain consumer trust.

If your brand relies on clean-label positioning or has questions about evolving FDA expectations, seeking experienced regulatory guidance with FDA Atty can help you move forward with confidence.